Lung Cancer Screening

Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol. 'Lung Cancer Screening' by Mark Parker and esteemed VCU Health colleagues, fulfils the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumours in the lungs, screening pros and cons, and interpreting/reporting screening results. * The evolution and future of lung cancer screenings. * Detection and management of unexpected incidental pulmonary and non-pulmonary findings. * Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings. * Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates. This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.

An aparitie	13 Dec 2017
Autor	Mark Parker ,‎ Robert C. Groves ,‎ Joanna E. Kusmirek
Dimensiuni	15.5 x 1 x 23.1 cm
Editura	Thieme Medical Publishers
Format	Paperback
ISBN	9781626235137
Limba	Engleza
Nr pag	120